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Abstract
Objectives—Occupational exposure to chlorinated aliphatic solvents has been associated with an 
increased cancer risk, including brain cancer. However, many of these solvents remain in active, 
large-volume use. We evaluated glioma risk from non-farm occupational exposure (ever/never and 
estimated cumulative exposure) to any of the six chlorinated solvents—carbon tetrachloride, 
chloroform, methylene chloride, trichloroethylene, tetrachloroethylene or 1,1,1-trichloroethane—
among 798 cases and 1175 population-based controls, aged 18–80 years and non-metropolitan 
residents of Iowa, Michigan, Minnesota and Wisconsin.
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Methods—Solvent use was estimated based on occupation, industry and era, using a 
bibliographic database of published exposure levels and exposure determinants. Unconditional 
logistic regression was used to calculate ORs adjusted for frequency matching variables age group 
and sex, and age and education. Additional analyses were limited to 904 participants who donated 
blood specimens (excluding controls reporting a previous diagnosis of cancer) genotyped for 
glutathione-S-transferases GSTP1, GSTM3 and GSTT1. Individuals with functional GST genes 
might convert chlorinated solvents crossing the blood–brain barrier into cytotoxic metabolites.
Results—Both estimated cumulative exposure (ppm-years) and ever exposure to chlorinated 
solvents were associated with decreased glioma risk and were statistically significant overall and 
for women. In analyses comparing participants with a high probability of exposure with the 
unexposed, no associations were statistically significant. Solvent-exposed participants with 
functional GST genes were not at increased risk of glioma.
Conclusions—We observed no associations of glioma risk and chlorinated solvent exposure. 
Large pooled studies are needed to explore the interaction of genetic pathways and environmental 
and occupational exposures in glioma aetiology.
INTRODUCTION
Six chlorinated solvents—carbon tetrachloride, chloroform, methylene chloride, 
trichloroethylene, tetrachloroethylene and 1,1,1-trichloroethane—have been in wide 
commercial use with millions of workers worldwide exposed.1 The International Agency for 
Research on Cancer (IARC) has evaluated carbon tetrachloride, chloroform and methylene 
chloride as possible human carcinogens, trichloroethylene and tetrachloroethylene as 
probable human carcinogens and 1,1,1-trichloroethane as having insufficient data to 
evaluate human carcinogenicity.2–6 IARC has scheduled a meeting for October 2012 to re-
evaluate the assessments of trichloroethylene and tetrachloroethylene.
Much has been written on the health effects, especially cancer, associated with exposure to 
these solvents, including a number of recent reviews17–10 but there are few studies of 
chlorinated solvent exposure and brain cancer, and fewer limited to gliomas. A case-only 
study in Shanghai, China, assigned women with brain cancer a low or high level of exposure 
to organic solvents, based on occupation. Those with a high probability of high solvent 
exposure had a nearly two-fold risk.11 A case–control study in Sweden found a greater than 
two-fold relative risk of glioma for men who self-reported exposure to ‘solvents, degreasers 
or cleaning agents’.12 There was no significant increase in risk for women. Three 
consecutive case–control studies of glioma and other cause deaths used occupational 
information from death certificates,13 next-of-kin interviews14 and job-exposure 
matrices1516 to estimate solvent exposure with the strongest association for methylene 
chloride and risk of glioma with increasing probability of exposure and with increasing 
duration of exposure in high-exposed jobs.15 Using a different set of job-exposure matrices 
associating women's occupations on death certificates with estimated intensity and 
probability of exposure to chlorinated solvents, Cocco et al17 found an increased risk for 
solvents and, in particular, for methylene chloride by increasing probability of exposure, but 
not by intensity of exposure.
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The glutathione-S-transferase (GST) enzymes are involved in phase II detoxification 
pathway for chlorinated solvents (the phase I pathway employs cytochrome P450).18 
Although GST is considered a detoxification pathway for many chemicals, in the case of 
certain chlorinated solvents, it is the GST pathway that has been most strongly implicated in 
genotoxicity and carcinogenicity.1920 Humans with fully functional GST genes (GST-
positive) could theoretically produce enzymes that metabolise chlorinated solvents to 
cytotoxic metabolites; those with less functional or nonfunctioning genes (GST-null) have 
little or no enzyme and apparently do not produce cytotoxic metabolites from chlorinated 
solvent exposure. GSTP1 and GSTM3 enzymes are produced in the brain21–23 and GSTT1 
is expressed in the brain.24 Some studies have found an association between GSTP1 
genotypes and glioma risk192526 although other studies have seen no increased risk.202123 It 
has also been reported that GSTT1-null individuals are at increased risk of glioma.27 
Because chlorinated solvents can cross the blood–brain barrier28 the cytotoxic metabolites 
might be produced in brain tissue in individuals with fully functional GSTP1, GSTM3 or 
GSTT1 enzymes.
In 1995, the National Institute for Occupational Safety and Health (NIOSH) initiated the 
Upper Midwest Health Study (UMHS), a population-based case–control study of glioma 
risk in a non-metropolitan population. The main focus was farming and associated rural risk 
factors.29 The questionnaire also included a complete non-farm occupational history so 
‘exposures of interest’ on non-farming jobs, including those to chlorinated solvents, could 
be assessed.
The analyses presented here evaluated associations between risk of glioma and exposures 
from non-farming jobs (ever/never and estimated cumulative) to any of six chlorinated 
solvents—carbon tetrachloride, chloroform, methylene chloride, trichloroethylene, 
tetrachloroethylene or 1,1,1-trichloroethane—among study participants. We did not consider 
farm jobs when evaluating chlorinated solvent exposure because the literature on farmer 
solvent use was very meagre and because farmers tend to use non-chlorinated solvents for 
farm tasks, as our paper on farm activities reported.30 However, all non-farm jobs reported 
by farmers were evaluated for chlorinated solvent exposure. The primary hypothesis was 
that at least one of these chlorinated solvents would be associated with increased glioma 
risk. In addition, we hypothesised that among genotyped participants risk would differ by 
genotype.
MATERIALS AND METHODS
The study sample and design have been described previously.29 Residents of non-
metropolitan counties of Iowa, Michigan, Minnesota and Wisconsin at diagnosis (cases) 
between 1 January 1995 and 31 January 1997 or resident (controls) on 1 January 1995 were 
eligible to participate. The four study states have large farm populations and higher than 
average brain cancer incidence. Using the distribution by sex and age at diagnosis (by ten-
year age groups) of gliomas during a three-year period (1989–1992) in the study states, we 
selected potential controls (2:1 to projected number of cases) from state driver's license 
records (ages 18 to 64 years) or from Health Care Financing Administration's (HCFA) 
Medicare data tapes (ages 65–80 years). Sampling randomly within sex-age strata across 
Ruder et al. Page 3













eligible counties, we chose a pool of potential controls as the case enrolment began. 
Participants reporting prior malignancies other than glioma (6.4% of cases, 20.6% of 
controls) were not excluded.
The study focused on histologically confirmed primary intracranial gliomas, (ICD-O code 
938–948),31 rather than all brain neoplasms, to reduce heterogeneity among the case 
participants. Cases were identified through participating medical facilities and neurosurgeon 
offices. Case ascertainment, assessed by comparison with respective state tumour registries 
for eligible counties, was 78% overall.29 Physician consent was obtained before contacting 
cases or their next-of-kin. Potential participants received a letter of invitation and a follow 
up telephone call to request participation. Informed consent was solicited from all potential 
participants. Among eligible potential participants, 70.4% of 1669 controls and 91.5% of 
872 cases (or their next-of-kin) agreed to participate, resulting in a study population of 1175 
controls and 798 cases.29 Interviews with participants (many with family members also 
taking part) were conducted for 199/462 (43%) glioblastoma cases, 239/336 (72%) other 
glioma cases and 1141/1175 (97%) controls. Cases (n=438) were interviewed in person at an 
average of 196 days after diagnosis; proxy case interviews (n=360) occurred at an average 
of 420 days after diagnosis (partly due to waiting after a case death before approaching 
family members). Among cases, 58% had a diagnosis of glioblastoma multiforme 
(equivalent to stage 4 glioma); 22%, astrocytoma; 11%, oligodendroglioma; 8%, other 
glioma subtypes.
This study was approved by the NIOSH Human Subjects Review Board (HSRB 94-
DSHEFS-08) and review boards of all participating institutions.
The questionnaire, modified from one developed by the National Cancer Institute,32 
included a complete occupational history. Respondents were asked about all jobs of at least 
a year's duration between the age of 16 years and the end of 1992, including employer name, 
industry, job title, job tasks, materials used and employment frequency. The questionnaire 
also asked specifically about certain exposures, including ‘solvents, thinners, glues, inks, 
varnishes, stains or paint strippers’, and on which jobs and for how many hours a week these 
exposures occurred.
For this analysis, the probability, intensity and frequency of exposure to six chlorinated 
solvents—carbon tetrachloride, chloroform, methylene chloride, trichloroethylene, 
tetrachloroethylene and 1,1,1-trichloroethane—in non-farm jobs was estimated based on 
occupation, industry and decade, using our annotated appendix of sources of exposure data33 
as well as bibliographic databases of published exposure levels.3435 We estimated values for 
a set of exposure determinants,33 with an algorithm linking participants, jobs and exposure 
determinants (The process is illustrated graphically in the online supplementary figure S1).
The jobs dataset contained 12 145 observations (participant-jobs) for 1967 participants (six 
participants were 16 years of age in 1993 with no jobs recorded), including 4067 
observations of gaps in the work histories. Information reported by the respondent on 
employment frequency was used to assign two quantitative factors: employment status (full 
or part time) and seasonality, based on the fraction worked during a year. In the absence of 
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information, these were assumed to be 1. This information was necessary for cumulative 
exposure calculations (described below).
The exposure file contained six records for each job, one for each solvent. An industrial 
hygienist (IH), blinded to case–control status, reviewed the job information and assigned the 
following for each of the chlorinated solvents: (1) Probability of exposure (0=not exposed, 
1=<0.1, 2=0.1–0.49, 3=0.50–0.89, 4>0.89), (2) frequency of exposure (0: not exposed, 1:1 
h/week, 2: 2–10 h/week, 3: 11–20 h/week, 4: >20 h/week), (3) degree of confidence in the 
probability assignment (1=no information, 2=solvent present, 3=solvent use described 
relatively, 4=solvent use described quantitatively) and (4) degree of confidence in the 
frequency assignment (1=low to 4=high).
For jobs with probability of exposure >0, the IH additionally assigned values for the 
following exposure determinants: (1) primary mechanism of release, (2) secondary 
mechanism of release, (3) ventilation type and effectiveness, (4) process condition, (5) 
quantity, (6) temperature, (7) proximity to source, (8) location (indoor/outdoor), (9) confined 
space and (10) an indication of the confidence associated with the determinant assignments. 
These determinants were used to model intensity from measurement data in the published 
literature. Details about the exposure determinants and how they were used in computing 
exposure levels have been described.33
Exposure status was assigned to each job. Jobs assigned a zero probability of exposure were 
considered to be not exposed and assigned 0 ppm-years for continuous cumulative exposure 
variables. Jobs assigned a probability of exposure >0 were considered to be exposed and a 
continuous cumulative exposure was estimated as follows. First, each job was split so as to 
have one observation for each calendar year the job was held and duration of exposure 
(days) for each year the job was held, was calculated from the split job start and end dates. 
Next, exposure frequency factor values were assigned as 1 for ‘1 h/week’, 6 for ‘2–10 h/
week’, 15 for ‘11–20 h/week’, and 30 for ‘>20 h/week’. These were converted to 1/7 (0.14) 
h/day, 6/7 (0.86) h/day, 15/7 (2.14) h/day, or 30/7 (4.30) h/day for cumulative exposure 
calculations. For methylene chloride, 1,1,1-trichloroethane and trichloroethylene, exposure 
intensity (ppm) was calculated from 1975 (1955 for trichloroethylene) to 1995 using the 
exposure-determinants models as previously described.33 The modelled intensity for 1975 
was assigned to all prior years for methylene chloride and 1,1,1-trichloroethane whereas the 
modelled intensity for 1955 was assigned to all prior years prior for trichloroethylene, based 
on the availability of measurements. For carbon tetrachloride, chloroform and 
tetrachloroethylene, exposure intensity was assigned using the estimated methylene chloride 
exposure intensity and a vapour pressure conversion factor based on the Ideal Gas Law to 
convert the estimated methylene chloride exposure intensity to an intensity for each of the 
other solvents (tetrachloroethylene, carbon tetrachloride and chloroform). Finally, 
cumulative exposure (ppm-h) for each solvent-worker-job-year was the product of duration 
(days), employment frequency (unitless), exposure frequency (h/day) and exposure intensity 
(ppm). Cumulative exposure (ppm-h) for each worker was the sum of the cumulative 
exposures for all job-years. Exposures were converted to ppm-years, with 1 ppm-year equal 
to 2000 ppm-h.
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Analyses were conducted using dichotomous exposures (ever/never exposed) for each 
solvent for all participants and separately for men and women. Since exposure to chlorinated 
solvents has been associated with a number of cancers, we also performed some analyses 
excluding controls who had reported having had cancer. Unconditional logistic regression 
modelling adjusted for the frequency-matching variables (10-year age group and sex), and 
for age and education (less than high school, high school graduate (referent group), post 
high-school education), as a surrogate for socioeconomic status, to obtain maximum-
likelihood parameter estimates for each solvent exposure. Age was included as well as age 
group to adjust for residual confounding within age groups.3637 We repeated the categorical 
analysis limiting the “exposed” category to participants with a high probability of having 
been exposed (ie, 0.5 or higher).
Additional analyses used a natural log transformation of continuous exposures in ppm-years, 
with a small number (−10) substituting for zero exposures. Analyses were repeated 
separately, for male and female participants and excluding participants with zero estimated 
exposure. We report results both including and excluding proxy responses in tables (in the 
text, unless noted, we report only results including proxy responses). For all analyses, we 
used the SAS V.9.1 software.
Since genetics affects how chemicals are metabolised we wanted to investigate the possible 
effect of differences in enzymes that metabolise chlorinated solvents, the glutathione-S-
transferases. Individuals with functional (positive) GST genes might convert chlorinated 
solvents crossing the blood–brain barrier into cytotoxic metabolites. These analyses 
excluded 124 cases and 232 control participants who declined to donate blood specimens, 
347 cases who were deceased or too ill to ask, 360 controls who were not asked to donate a 
blood specimen, and, for each analysis, participants whose specimens had not been 
successfully genotyped. Since exposure to chlorinated solvents has been associated with a 
number of cancers, these analyses also excluded controls who reported having had cancer 
(n=111 for GSTP1 and 120 for GSTM3 and GSTT1).
In analyses restricted to participants genotyped for GSTP1 (322 cases and 456 controls 
genotyped), GSTM3 (316 cases and 443 controls genotyped) and GSTT1 (319 cases and 450 
controls genotyped) we compared risk of glioma by genotype within solvent exposure 
groups (exposed or unexposed), postulating that any genetic effect would be more 
pronounced in the solvent-exposed group. In these analyses we do not present results 
excluding proxies, since all but ten blood donors personally completed the questionnaire 
interview.
Laboratory methods: Some 325 cases (41% of all participating cases or 71% of 458 alive at 
the time of interview) and 579 controls (73% of 793 asked) provided blood specimens. DNA 
was extracted from whole-blood specimens using a sodium perchlorate–chloroform 
method.38 At the time of DNA extraction, PCR/restriction fragment length polymorphism 
reactions were conducted by GenoType, Ltd (UK) to characterise GSTP1 Il05V rs1695 A/G 
and A114V rs1138273 C/T using a minor modification of the procedure described by 
Watson et al39 and GSTT1 (null) was characterised using genotyping methods described by 
Pemble et al40 and Chenevix-Trench et al41 For GSTP1, among 904 specimens, we 
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excluded 9 specimens that lacked genotyping results and 120 specimens from controls who 
had reported having had cancer, leaving 778 specimens in the analysis.
For GSTT1, there were 904 specimens; 15 lacking genotyping results and 120 from controls 
who had reported having had cancer were excluded, leaving 769 specimens in the analysis.
GSTM3 *A/*B was genotyped at the NCI Core Genotyping Facility, Gaithersburg, MD, 
using high-throughput (TaqMan) procedures. *B has a 3 base pair deletion in intron 6. 
Specific details on primers, reaction conditions and amplification procedures are described 
in http://variantgps.nci.nih.gov/cgfseq/pages/resultSubmit.do?
method=getPlatform&assayLid=001_0777. Among 881 specimens available, 11 lacked 
genotyping results and 111 were from controls who had reported having had cancer, and 
were therefore excluded, leaving 759 specimens in the analysis.
RESULTS
Numbers of cases and controls and basic demographics are presented in table 1. Almost all 
participants had held non-farm jobs, and the distributions of longest jobs over broad 
categories (professional, trade or service) were similar. When proxy-only interviews were 
excluded, cases were more likely to have graduated from college and high school than were 
controls. As reported by us previously, controls were significantly older than cases (table 
1)29
For 283 cases (35%, 69 women, 214 men) and 475 controls (40%, 144 women, 331 men) 
occupational exposure to ‘solvents, thinners, glues, inks, varnishes, stains or paint strippers’ 
was reported. Based on all the reported occupational information, exposure to at least one 
solvent was assigned to 359 cases (45%, 244 men, 115 women) and 570 controls (49%, 364 
men, 206 women). Ever exposure to each of the six solvents, or to any chlorinated solvent, 
was associated with a decreased risk of glioma (table 2). Results were similar for men and 
women considered separately although the odds were higher for men and the CIs for men all 
included one. When data from proxy interviews were excluded, the odds of a positive 
association with glioma were slightly higher for men, but still below 1.0. The association did 
not change when controls who reported having had cancer were excluded (results not 
shown).
When we repeated the categorical analysis comparing “exposed” participants with a high 
probability of having been exposed (ie, 0.5 or higher) to the unexposed, results (not shown) 
were similar. However, because the numbers of “highly probable to have been exposed’ 
participants were much smaller, none of the associations were statistically significant.
Adjusted ORs for estimated cumulative exposure to each of the six solvents were associated 
with statistically significant reduced risks of glioma (table 3A). In separate analyses for men 
and women, all ORs were associated with reduced glioma risk but only the results for 
women were statistically significant (results not shown). We repeated the analysis excluding 
the unexposed participants (table 3B). The mean cumulative levels were higher than those 
for all participants, ranging from 3.5 to 98.9 ppm-years, but the odds did not change 
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appreciably; because the numbers of included participants were lower, the CIs were wider 
and none of the ORs were statistically significant.
Table 4 compares glioma risk separately for chlorinated-solvent-exposed and unexposed 
cases and controls genotyped for glutathione-S-transferases. Proxy-excluded results are not 
presented because proxy interviews were done for only 10 blood donors. For GSTM3, 
among 881 specimens, 11 lacking genotyping results and 111 from controls who had 
reported having had cancer were excluded, leaving 759 in the analysis. For GSTP1, among 
904 specimens, 9 lacking genotyping results and 120 from controls who had reported having 
had cancer were excluded, leaving 778 in the analysis. For GSTT1, among 904 specimens, 
15 lacking genotyping results and 120 from controls who had reported having had cancer 
were excluded, leaving 769 specimens in the analysis.
Participants who did not have the GSTM3 *B deletion on either chromosome (GSTM3 
*A*A), and therefore had a fully functioning enzyme, could theoretically, if exposed to 
chlorinated solvents, produce cytotoxic metabolites. However, the association with glioma 
risk was lower among those exposed to chlorinated solvents than among those not exposed 
to chlorinated solvents. Participants with the GSTP1 I105V I->V polymorphism were at a 
greater risk of glioma in an analysis unadjusted for solvent exposure or other factors 
(unadjusted OR 1.2, 95% CI 0.9 to 1.6) so we assumed they comprised the higher risk 
group. GSTT1-null participants were at a slightly elevated but not statistically significant 
risk of glioma. Table 4 shows there was no difference in risk by genotype within or across 
solvent exposure groups.
DISCUSSION
Occupational exposure to chlorinated solvents has been associated with a number of adverse 
health effects, including cancer.1 The association with brain cancer in general, and glioma in 
particular, has been inconsistent. In our study of exposure to six chlorinated solvents and 
glioma, we did not find a higher risk of glioma among solvent-exposed participants. 
Furthermore, we did not see a difference in risk between men and women. Using a 
bibliographic database of published exposure levels and exposure determinants, we 
developed a metric of cumulative chlorinated solvent exposure; however, the findings 
remained unchanged. Our results suggest that exposure to chlorinated solvents does not 
increase the risk of glioma.
Study strengths include the large number of histologically confirmed gliomas and the use of 
population-based controls. Another strength was the estimation of workplace exposure 
determinants by industrial hygienists blinded to the case–control status of participants, with 
documented published literature to rigorously estimate intensity. The large percentage of 
proxy case respondents and possible poor recall by case respondents could have affected the 
analysis if work details that might be associated with chlorinated solvent exposure were less 
specific for case than for control responses. Since controls were generally older (table 1) and 
started working during earlier eras, their opportunity for an assessment of greater exposure 
by the industrial hygienists was higher. The algorithm for sampling controls from the motor 
vehicle registration and Medicare rolls was based on the distribution by gender and age at 
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diagnosis (by ten-year age groups) of glioma cases during a 3-year period (1989–1992) in 
the four study states. The distribution of diagnosed cases during our study period turned out 
to be skewed toward younger age at diagnosis; this is how the case–control age difference 
arose. For this analysis, specific limitations include the lack of detailed information from 
participants about occupational exposures which could have been used to confirm the 
exposures estimated on the basis of occupation, industry and decade. Another limitation, 
from using a statistical model based on published measurements to estimate intensity, is our 
assumption that the exposure levels in the workplaces of study participants fell within the 
range of exposures in workplaces reported in the literature.
Most of the earlier studies of solvent exposure and brain cancer had greater limitations. Only 
one previous study12 included interviews with cases and controls. In the others, occupational 
information was obtained entirely from cases,11 from proxies13–15 or was based on a single 
occupation on a death certificate.17 Of the two population-based participant-interviewed 
case–control brain cancer studies reporting on solvent exposure to date, Rodvall et al12 
reported a positive association based on self-reported and assessed exposure to solvents 
(benzene, toluene, trichloroethylene and xylene) by 15 cases and 20 controls. With 359 
cases and 570 controls with expert-assessed exposure to chlorinated solvents, we found no 
positive association. Rodvall et al study and ours are inconsistent, but had only one solvent 
(trichloroethylene) in common.
Exposures to chlorinated solvents on the farm were not considered in these analyses. 
Although all or almost all farmers are exposed to solvents, they generally do not use 
chlorinated solvents. We reported on solvent use associated with farm tasks; most of the 
reported use was to gasoline, kerosene or other petroleum-based solvents.30 Chlorinated 
solvent use by farmers in non-farm jobs was included in the analyses.
Our findings for the genotyped participants (table 4) were unexpected. Theoretically, if the 
cytotoxic metabolites of chlorinated solvents were the major cancer risk factor for 
individuals exposed to chlorinated solvents, we would have expected an increased risk of 
cancer among participants with the non-deleted genotypes for GSTP1, GSTM3, and GSTT1, 
who were capable of producing the cytotoxic metabolites, and who were exposed to 
chlorinated solvents. Our results showed no association. This could be due to the cytotoxic 
metabolites of chlorinated solvents not being the major risk factor, chlorinated solvent 
exposure not being a risk factor for glioma, or heterogeneity among the genotypes for other 
genes in the chlorinated solvent metabolic pathways. Our results are in agreement with a 
meta-analysis of eight studies (including ours), that did not find an association between GST 
polymorphisms and the risk of brain tumours.42
The associations we saw may be due to some factor, linked to chlorinated solvent exposure 
that we did not study, such as being fit enough to work in occupations with elevated solvent 
exposure. A theoretical “unhealthy worker” effect could affect participants with glioma, but 
only if asymptomatic individuals began to experience problems long before their diagnoses. 
Recent genetic work provides some support for this theory. Isocitrate dehydrogenase 
mutations apparently occur frequently in gliomas, mimicking an inborn error of metabolism, 
L-2-hydroxyglutaric aciduria.4344 Individuals born with this neurometabolic disorder have 
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neurological symptoms, fatigue and balance problems, increasing as hydroxyglutamate 
accumulates.45 Individuals in whom such mutations occurred later in life might begin 
experiencing similar symptoms and become less likely to hold jobs requiring moderate or 
greater physical activity and/or involving machinery, that is, jobs more likely than sedentary 
desk jobs to be associated with solvent exposure. However, we compared declared ‘age at 
retirement’ for those participants who volunteered this information and saw no difference 
between cases and controls (results not shown). Lack of knowledge about work details by 
proxies of cases and memory problems in cases, compared with relatively healthy controls; 
the earlier entry into the work force, during eras in which solvent exposure was higher, of 
controls; and the slightly higher education level of cases, which could have resulted in their 
working in jobs with less opportunity for hands-on exposure to solvents, are more likely 
explanations for the differences we saw in assessed solvent exposure.
CONCLUSION
In our study population, both estimated cumulative exposure (ppm-years) and estimated ever 
exposure to chlorinated solvents were associated with decreased risk of glioma and were 
statistically significant overall and for women. Analyses excluding unexposed participants 
had similar, but not statistically significant, results. In analyses comparing participants with 
a high probability of exposure with the unexposed none of the associations were statistically 
significant. Solvent-exposed participants with functional glutathione-S-transferases GSTP1, 
GSTM3 and GSTT1 were not at increased risk of glioma. Large pooled studies should be 
undertaken to explore the interaction of genetic pathways and environmental and 
occupational exposures
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What this study adds
▶ Chlorinated solvents are known neurotoxicants.
▶ Chlorinated solvents are probable carcinogens.
▶ Quantitative chlorinated solvent exposure is not associated with an increased risk 
of glioma.
▶ Glutathione-S-transferase genotypes do not affect the glioma-solvent association 
among those exposed to chlorinated solvents.
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